Sort
39,280 grants matching “leukemia”
Therapeutic Opportunities for Pediatric Astrocytoma
$1,496,990Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2013 · CA
Cellular and Molecular Studies of Bone Marrow Transplant
$1,496,702University Of Michigan At Ann Arbor · P01 · FY2005 · CA
improving outcomes after stem cell transplantation
$1,496,532Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS
$1,496,276Jagath Junutula · Cellerant Therapeutics, Inc. · N44 · FY2016 · CA
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,494,684Chi-Chao Chan · National Eye Institute · ZIA · FY2011 · EY
Molecular Assays for epidemiology studies
$1,493,361David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
ETIB Clinical Research Core
$1,492,154Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
ETIB Clinical Trials
$1,492,154Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Immunology And Pathology Of Murine Leukemia Virus Infections
$1,491,179Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
DCTD Screening Technologies
$1,490,565David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
$1,489,451James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2019 · NS
Human Immune System Humanized Modeling of Down Syndrome Immune Responses to Pluripotent Stem Cells
$1,488,578Matthew E Brown · University Of Wisconsin-Madison · R24 · FY2025 · AI
ETIOLOGY OF TREATMENT INDUCED SECONDARY LEUKEMIA
$1,487,682University Of Chicago · P01 · FY2000 · CA
Leukemia Signatures for Risk Classification &Targeting
$1,487,298University Of New Mexico · U01 · FY2005 · CA
The 10,000 Families Cohort: a new study to understand the environmental causes of cancer
$1,486,611Jenny N. Poynter · University Of Minnesota · UH3 · FY2025 · CA
Flow Cytometric Analysis of Benign and Malignant Tumors
$1,485,535Maryalice Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIC · FY2010 · CA
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,484,521Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Discovery of Anticancer Agents of Diverse Natural Origin
$1,484,104Alan Douglas Kinghorn · Ohio State University · P01 · FY2014 · CA
Cellular and Molecular Studies of Bone Marrow Transplant
$1,481,204University Of Michigan At Ann Arbor · P01 · FY2004 · CA
Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies
$1,481,031Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Mammalian Development and Evolution
$1,479,254Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Cellular Pathways of Oncogenesis
$1,478,690Princeton University · P01 · FY2005 · CA
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,478,374Julie R Park · Seattle Children'S Hospital · U01 · FY2018 · TR
Temporal & spatial organization of signaling complexes in T & B Cells
$1,476,957Gary A. Koretzky · University Of Pennsylvania · P01 · FY2007 · CA
Temporal & spatial organization of signaling complexes in T & B Cells
$1,476,071Gary A. Koretzky · University Of Pennsylvania · P01 · FY2008 · CA